Interview CEO FLUIDDA Jan de Backer on presented posters at the ATS 2019

At the recent ATS 2019 conference in Dallas, Texas, two posters were presented on research using Fluidda’s Functional Respiratory Imaging (FRI) technnology.

Using FRI technology can reduce the sample size and duration of clinical trials and in this way can have an impact on the costs of the trials.

Fluidda’s founder and CEO Jan de Backer explaines why in this video.

Sorry, comments are closed for this post.